These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12766002)

  • 1. Comparison of the Biomedica NT-proBNP enzyme immunoassay and the Roche NT-proBNP chemiluminescence immunoassay: implications for the prediction of symptomatic and asymptomatic structural heart disease.
    Mueller T; Gegenhuber A; Poelz W; Haltmayer M
    Clin Chem; 2003 Jun; 49(6 Pt 1):976-9. PubMed ID: 12766002
    [No Abstract]   [Full Text] [Related]  

  • 2. Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease.
    Mueller T; Gegenhuber A; Poelz W; Haltmayer M
    Clin Chim Acta; 2004 Mar; 341(1-2):41-8. PubMed ID: 14967157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natriuretic peptides as markers of mild forms of left ventricular dysfunction: effects of assays on diagnostic performance of markers.
    Hammerer-Lercher A; Ludwig W; Falkensammer G; Müller S; Neubauer E; Puschendorf B; Pachinger O; Mair J
    Clin Chem; 2004 Jul; 50(7):1174-83. PubMed ID: 15142976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide.
    Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A
    Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A chemiluminescence immunoassay for the detection of NT-proBNP.
    Chen YY; Li SL; Lin HL; Li WD; Zhu XZ; Zhang HL
    Anal Biochem; 2020 Dec; 611():113950. PubMed ID: 32919941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
    Hess G; Runkel S; Zdunek D; Hitzler WE
    Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea.
    Alibay Y; Beauchet A; El Mahmoud R; Schmitt C; Brun-Ney D; Benoit MO; Dubourg O; Boileau C; Jondeau G; Puy H
    Biomed Pharmacother; 2005; 59(1-2):20-4. PubMed ID: 15740931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure.
    Bruins S; Fokkema MR; Römer JW; Dejongste MJ; van der Dijs FP; van den Ouweland JM; Muskiet FA
    Clin Chem; 2004 Nov; 50(11):2052-8. PubMed ID: 15345664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of a competitive NT-proBNP enzyme immunoassay compared to the Roche NT-proBNP platform.
    Hammerer-Lercher A; Griesmacher A; Pölzl G; Brinskelle-Schmal N; Mair J; Frick M; Hawa G
    Clin Chem Lab Med; 2009; 47(10):1305-8. PubMed ID: 19751139
    [No Abstract]   [Full Text] [Related]  

  • 10. N-Terminal pro-brain natriuretic peptide: normal ranges in the pediatric population including method comparison and interlaboratory variability.
    Albers S; Mir TS; Haddad M; Läer S
    Clin Chem Lab Med; 2006; 44(1):80-5. PubMed ID: 16375591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis.
    Palladini G; Campana C; Klersy C; Balduini A; Vadacca G; Perfetti V; Perlini S; Obici L; Ascari E; d'Eril GM; Moratti R; Merlini G
    Circulation; 2003 May; 107(19):2440-5. PubMed ID: 12719281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Amino-terminal pro-brain natriuretic peptide and brain natriuretic peptide measurements under various detection conditions in patients with chronic heart failure].
    Wang WJ; Zhang XM; Wang Q; Wen DM; Ouyang NL; Cui YL; Li F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):695-9. PubMed ID: 22169413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of NT-proBNP with LOCI technology in heart failure patients.
    Gruson D; Ahn SA; Lepoutre T; Rousseau MF
    Clin Biochem; 2012 Jan; 45(1-2):171-4. PubMed ID: 21843519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non-radioimmunometric NT-ProBNP and BNP assays: impact of diluent, age, gender, BMI].
    Alibay Y; Schmitt C; Beauchet A; Dubourg O; Alexandre JA; Boileau C; Jondeau G; Puy H
    Ann Biol Clin (Paris); 2005; 63(1):43-9. PubMed ID: 15689311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Dong H; Chen DQ; Wang Y; Li M
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay.
    Yeo KT; Wu AH; Apple FS; Kroll MH; Christenson RH; Lewandrowski KB; Sedor FA; Butch AW
    Clin Chim Acta; 2003 Dec; 338(1-2):107-15. PubMed ID: 14637274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker responses during and after treatment with nesiritide infusion in patients with decompensated chronic heart failure.
    Miller WL; Hartman KA; Burritt MF; Borgeson DD; Burnett JC; Jaffe AS
    Clin Chem; 2005 Mar; 51(3):569-77. PubMed ID: 15615816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Abbott AxSYM and Roche Elecsys 2010 for measurement of BNP and NT-proBNP.
    Chien TI; Chen HH; Kao JT
    Clin Chim Acta; 2006 Jul; 369(1):95-9. PubMed ID: 16515777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.
    Januzzi JL; Camargo CA; Anwaruddin S; Baggish AL; Chen AA; Krauser DG; Tung R; Cameron R; Nagurney JT; Chae CU; Lloyd-Jones DM; Brown DF; Foran-Melanson S; Sluss PM; Lee-Lewandrowski E; Lewandrowski KB
    Am J Cardiol; 2005 Apr; 95(8):948-54. PubMed ID: 15820160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [NT-proBNP measurement on Immulite 2500 (DPC): analytical performance and comparison with Roche Diagnostics and Dade-Behring NT-proBNP immunoassays].
    Cauliez B; Boucher S; Duflo-Leroy A; Lavoinne A
    Ann Biol Clin (Paris); 2007; 65(1):93-8. PubMed ID: 17264046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.